We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Irene Hramiak

Irene M. Hramiak MD, FRCP(C), MACP

Professor, Department of Medicine, Division of Endocrinology and Metabolism, Western University; Department of Medicine Site Chief, St. Joseph’s Hospital; Endocrinologist, St. Joseph’s Health Care London, London, Ontario, Canada

Irene M. Hramiak, MD, FRCP(C), MACP, is a Professor of Medicine, Western University, London, ON. She is the current Department of Medicine Site Chief at St. Joseph’s Hospital.

Dr. Hramiak practices Endocrinology at St. Joseph’s Hospital in London, Ontario, with a strong clinical interest in Type 1 and Type 2 diabetes mellitus.

Dr. Hramiak has held peer reviewed funding from JDRF, CDA, and the NIH since 1983; she was a co-investigator in the DCCT (1983-2000), for which she was awarded the Charles H. Best Award for distinguished service by the American Diabetes Association in 1993. In 2016, she was awarded the Canadian Diabetes Association’s Gerald S Wong Service Award. She has been a Principle Investigator in many cardiovascular outcome trials in Type 2 diabetes mellitus, including: ACCORD, ORIGIN, TECOS, LEADER, SUSTAIN, REWIND, and DECLARE-TIMI 58. Dr. Hramiak was the Principle Investigator at Western University for the JDRF Ontario trial network. She has been a Principle Investigator for REMOVAL and other trials investigating benefits of new therapies in Type 1 Diabetes.

Dr. Hramiak has been recognized by ACP with a Mastership for Academic Excellence in 2020. Western University has awarded her the Alumni of Distinction Award in 2021.

Dr. Hramiak serves as an external advisor to many groups and pharmaceutical companies with regards to diabetes and obesity.

Disclosures

Dr. Hramiak reports the following:
  • Grants/Research Support: Novo Nordisk, Sanofi, Eli Lilly
  • Speakers Bureau/Honoraria:Bayer Inc., Boehringer Ingelheim, Eli Lilly, Insulet, Merck, Novo Nordisk
  • Consulting Fees: Boehringer Ingelheim, Eli Lilly, Medtronic, Merck, Novo Nordisk, Sanofi
  • Other: Employee of Western University

Recent Contributions to PracticeUpdate:

  1. Career Advancement for Women in Diabetes-Related Research